Genetic Linkage Studies of Stuttering
Launched by NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS (NIDCD) · Nov 3, 1999
Trial Information
Current as of March 21, 2025
Completed
Keywords
ClinConnect Summary
A primary goal of this study is to ascertain regions of the human genome which show genetic linkage to stuttering. Genetic linkage will be determined by first obtaining genomic DNA from both affected and unaffected adults and children from families containing pairs of individuals who stutter as adults. Individuals who stutter from genetically isolated populations will also be sampled. Phenotype will be assigned by a speech-language pathologist, and DNA samples will be obtained from affected and unaffected family members from 2 cc. of saliva or from 20 cc. of blood. These DNA samples will th...
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- • Individuals age 8 and older.
- • Individuals age 6-8 with a family history of persistent stuttering
- • Have stuttering that persists for a period of 6 months or more or are a family member of that person
- • For the Phase 2 imaging studies, we will be enrolling up to 25 healthy volunteers to be controls
- EXCLUSION CRITERIA:
- • Stuttering only as a young child (before age 5) with no other family members who stutter
- • Inability to provide informed consent or have a parent/guardian to provide consent
- • Development of stuttering following trauma to the central nervous system.
- • Chronic medical conditions that prevent informed consent or clear evaluation of stuttering, including stroke, dementia, and degenerative neurological disease.
- • Inability to travel to the NIH Clinical Center for Phase 2
Trial Officials
Joshua Levy, M.D.
Principal Investigator
National Institute on Deafness and Other Communication Disorders (NIDCD)
About National Institute On Deafness And Other Communication Disorders (Nidcd)
The National Institute on Deafness and Other Communication Disorders (NIDCD) is a prominent agency within the National Institutes of Health (NIH) dedicated to advancing research and understanding of hearing, balance, taste, smell, voice, speech, and language disorders. Through rigorous clinical trials and innovative research initiatives, the NIDCD aims to improve the diagnosis, treatment, and prevention of communication disorders, ultimately enhancing the quality of life for individuals affected by these conditions. The institute fosters collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical practices and public health strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Bethesda, Maryland, United States
Saitama, , Japan
Lahore, , Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials